EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes

Qinzheng Chang, Shuo Zhao, Jiajia Sun, Wei Guo, Lin Yang, Laiyuan Qiu, Nianzhao Zhang, Yidong Fan, Jikai Liu

Frontiers in Endocrinology · 2025

DOI: 10.3389/fendo.2025.1521940 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, 2025. Verfasst von Qinzheng Chang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Renin-Angiotensin System, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Clear cell renal cell carcinoma is the most predominant type of renal malignancies, characterized by high aggressiveness and probability of distant metastasis. Renin angiotensin system (RAS) plays a crucial role in maintaining fluid balance within the human body, and its involvement in tumorigenesis is increasingly being uncovered, while its role in ccRCC remains unclear.

Methods

WGCNA was used to identify RAS related genes. Machine learning was applied to screen hub genes for constructing risk model, E-MTAB-1980 dataset was used for external validation. Transwell and CCK8 assays were used to investigate the impact of SLC6A19 to ccRCC cells.

Results

SLC6A19, SLC16A12 and SMIM24 were eventually screened to construct risk model and the predictive efficiency for prognosis was validated by internal and external cohorts. Moreover, the differences were found in pathway enrichment, immune cell infiltration, mutational landscapes and drug prediction between high and low risk groups. Experimental results indicated that SLC6A19 could inhibit invasion and proliferation of ccRCC cells and GSEA pinpointed that SLC6A19 was intimately correlated with fatty acid metabolism and CPT1A.

Conclusion

The risk model based on the three RAS-related genes have a robust ability to predict the prognosis and drug sensitivity of ccRCC patients, further providing a valid instruction for clinical care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellRenin-Angiotensin SystemKidney NeoplasmsBiomarkers, TumorHumansPrognosisGene Expression Regulation, NeoplasticCell ProliferationMaleFemaleMonocarboxylic Acid TransportersCell Line, Tumor

Stichwörter der Autor:innen

CPT1aSLC6A19ccRCCrenin angiotensin systemrisk model

Substanzen

Biomarkers, TumorMonocarboxylic Acid Transporters

Autor:innen und Institutionen

  • Department of Urology, Qilu Hospital of Shandong University, Jinan, Shandong, China.

Zitieren

APA

Chang, Q., Zhao, S., Sun, J., Guo, W., Yang, L., Qiu, L., Zhang, N., Fan, Y., & Liu, J. (2025). Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2025.1521940

Vancouver

Chang Q, Zhao S, Sun J, Guo W, Yang L, Qiu L, et al. Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes. Frontiers in Endocrinology. 2025. doi:10.3389/fendo.2025.1521940

BibTeX
@article{Chang2025,
  author = {Chang, Qinzheng and Zhao, Shuo and Sun, Jiajia and Guo, Wei and Yang, Lin and Qiu, Laiyuan and Zhang, Nianzhao and Fan, Yidong and Liu, Jikai},
  title = {Identification of a novel prognostic and therapeutic prediction model in clear cell renal carcinoma based on Renin-angiotensin system related genes},
  journal = {Frontiers in Endocrinology},
  year = {2025},
  doi = {10.3389/fendo.2025.1521940}
}
Kostenlos starten →